References
-
1) D-serine metabolism in the medial prefrontal cortex, but not the hippocampus, is involved in AD/HD-like behaviors in SHRSP/Ezo.
Product: DAO Peptide (#DF7266-BP)Year: 2022Journal: Eur J PharmacolImpactFactor: 5DOI: 10.1016/j.ejphar.2022.174930PMID: 35364072 -
2) Chicken speckle-type POZ protein (SPOP) negatively regulates MyD88/NF-κB signaling pathway mediated proinflammatory cytokine production to promote the replication of Newcastle disease virus.
-
3) Augmentation of 3β-hydroxysteroid-Δ24 Reductase (DHCR24) Expression Induced by Bovine Viral Diarrhea Virus Infection Facilitates Viral Replication via Promoting Cholesterol Synthesis.
-
4) A Modified Fast Blocking Protocol for the Immunological Detection of Proteins.
Year: 2023Journal: SSRNDOI: 10.2139/ssrn.4467276 -
5) Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome.
-
6) Flavonoids from Smilax china L. Rhizome improve chronic pelvic inflammatory disease by promoting macrophage reprogramming via the NLRP3 inflammasome-autophagy pathway.
Year: 2023Journal: J FUNCT FOODSImpactFactor: 5.6DOI: 10.1016/j.jff.2023.105802 -
7) Iron induces B cell pyroptosis through Tom20–Bax–caspase–gasdermin E signaling to promote inflammation post-spinal cord injury.
Year: 2023Journal: J NeuroinflammationImpactFactor: 9.3DOI: 10.1186/s12974-023-02848-0PMID: 37480037 -
8) Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells.
-
9) Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury.
-
10) Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome.
-
11) Total flavones of Rhododendron induce the transformation of A1/A2 astrocytes via promoting the release of CBS-produced H2S.
Year: 2023Journal: PHYTOMEDICINEImpactFactor: 7.9DOI: 10.1016/j.phymed.2023.154666PMID: 36701996 -
12) Aucubin improves chronic unpredictable mild stress-induced depressive behavior in mice via the GR/NF-κB/NLRP3 axis.
Year: 2023Journal: Int ImmunopharmacolImpactFactor: 5.6DOI: 10.1016/j.intimp.2023.110677PMID: 37523973 -
13) FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer.
Product: FMO2 Antibody (#DF16081)Year: 2023Journal: Front OncolImpactFactor: 4.7DOI: 10.3389/fonc.2023.1144775PMID: 37274237 -
14) LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy.
Product: LRRC3B Antibody (#DF16048)Year: 2023Journal: Front ImmunolImpactFactor: 7.3DOI: 10.3389/fimmu.2023.959868PMID: 36798137 -
15) Directing Differentiation of Pluripotent Stem Cells Toward Retinal Pigment Epithelium Lineage.
Product: CLVS1 Antibody (#DF15830)Year: 2017Journal: Stem Cells Transl MedImpactFactor: 6DOI: 10.5966/sctm.2016-0088
- «
- »